AERES Biomedical - Disease Research & Prevention

Breaking News

AERES Biomedical and Lpath Therapeutics Sign Agreement to Humanize Sphingomab™ Antibody

December 23, 2021AERES BiomedicalLeave a Comment

London, UK, 12th September, 2005 – AERES Biomedical, Ltd. (London, UK) announced today that it has signed an agreement with Lpath Therapeutics Inc. (San Diego, USA) to humanize its Sphingomab™ antibody. Lpath will provide the murine antibody to AERES, which will use its proprietary humanization technology to provide a humanized Sphingomab™ clinical candidate. Financial terms […]

Pest Control is Vital To Disease Research

April 2, 2021AERES BiomedicalLeave a Comment

Information About Finding A Good Tucson Pest Control Company If you want to find the best pest control company out there, this guide is here to assist. You want to know for sure that you hire the right people for this kind of work so you can rid your dwelling of pests quickly and in […]

Brain Tumor Awareness Month: Can proton beam therapy improve the long-term quality of life of patients with oligodendroglioma brain tumors?
March 22, 2023
In a blog about enhancing neurocognition and quality of life in patients with brain tumors, Clinical Trial Coordinator Jaike Belgrave discusses the APPROACH study registered at the ISRCTN registry, the potential benefits of proton beam radiotherapy to long-term quality of […]
Promoting social interaction through emotional body odors: exploring the possible treatment value of human chemosignals
March 8, 2023
Emma Eliasson and colleagues discuss their study registered at the ISRCTN registry, which aims to find out whether exposure to body odors increases the effect of mindfulness treatment in patients with depressive and social anxiety symptoms.
Behçet’s Disease: Diverse manifestations in both brain and body
February 26, 2023
Orphanet Journal of Rare Diseases is proud to present this article by Olivia Noone, a runner-up entry in beacon for rare diseases and Medics4RareDiseases' "Student Voice" contest.